Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Jun 7;67(22):2593-603.
doi: 10.1016/j.jacc.2016.03.508. Epub 2016 Apr 4.

Effects of Vitamin D on Cardiac Function in Patients With Chronic HF: The VINDICATE Study

Klaus K Witte  1 , Rowena Byrom  2 , John Gierula  2 , Maria F Paton  2 , Haqeel A Jamil  2 , Judith E Lowry  2 , Richard G Gillott  3 , Sally A Barnes  3 , Hemant Chumun  2 , Lorraine C Kearney  2 , John P Greenwood  2 , Sven Plein  2 , Graham R Law  2 , Sue Pavitt  4 , Julian H Barth  5 , Richard M Cubbon  2 , Mark T Kearney  2
Affiliations
Randomized Controlled Trial

Effects of Vitamin D on Cardiac Function in Patients With Chronic HF: The VINDICATE Study

Klaus K Witte et al. J Am Coll Cardiol. .

Abstract

Background: Patients with chronic heart failure (HF) secondary to left ventricular systolic dysfunction (LVSD) are frequently deficient in vitamin D. Low vitamin D levels are associated with a worse prognosis.

Objectives: The VINDICATE (VitamIN D treatIng patients with Chronic heArT failurE) study was undertaken to establish safety and efficacy of high-dose 25 (OH) vitamin D3 (cholecalciferol) supplementation in patients with chronic HF due to LVSD.

Methods: We enrolled 229 patients (179 men) with chronic HF due to LVSD and vitamin D deficiency (cholecalciferol <50 nmol/l [<20 ng/ml]). Participants were allocated to 1 year of vitamin D3 supplementation (4,000 IU [100 μg] daily) or matching non-calcium-based placebo. The primary endpoint was change in 6-minute walk distance between baseline and 12 months. Secondary endpoints included change in LV ejection fraction at 1 year, and safety measures of renal function and serum calcium concentration assessed every 3 months.

Results: One year of high-dose vitamin D3 supplementation did not improve 6-min walk distance at 1 year, but was associated with a significant improvement in cardiac function (LV ejection fraction +6.07% [95% confidence interval (CI): 3.20 to 8.95; p < 0.0001]); and a reversal of LV remodeling (LV end diastolic diameter -2.49 mm [95% CI: -4.09 to -0.90; p = 0.002] and LV end systolic diameter -2.09 mm [95% CI: -4.11 to -0.06 p = 0.043]).

Conclusions: One year of 100 μg daily vitamin D3 supplementation does not improve 6-min walk distance but has beneficial effects on LV structure and function in patients on contemporary optimal medical therapy. Further studies are necessary to determine whether these translate to improvements in outcomes. (VitamIN D Treating patIents With Chronic heArT failurE [VINDICATE]; NCT01619891).

Keywords: heart failure; left ventricular function; remodeling; vitamin D.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Consort Diagram Demonstrating Patient Enrollment and Disposition for VINDICATE VINDICATE = VitamIN D treatIng patients with Chronic heArT failurE.
Figure 2
Figure 2
Median and Interquartile Ranges for Vitamin D, Creatinine, Calcium, and Parathyroid Concentrations at 3 Monthly Time Points in VINDICATE by Treatment Allocation Vitamin D concentrations are described in relation to deficiency (green line), sufficiency (orange line), and the accepted upper limit for hypervitaminosis D (red line). Serum calcium levels are described in relation to upper limit of normal range (red line), and serum parathyroid hormone concentrations in relation to the normal range (between red lines). Conversion factors: vitamin D nmol/l · 0.4 = ng/ml; creatinine mmol/l · 0.11 = mg/dl; calcium mmol/l · 4 = mg/dl; parathyroid hormone pmol/l · 9.4 = pg/ml. VINDICATE = VitamIN D treatIng patients with Chronic heArT failurE.
Figure 3
Figure 3
Median and Interquartile Ranges for 6-Minute Walk Test Distance, and LVEF, LVEDD, and LVEDV Measured by Echocardiography at Baseline and Final Visit in VINDICATE by Treatment Allocation LVEDD = left ventricular end-diastolic dimension; LVEDV = left ventricular end-diastolic volume; LVEF = left ventricular ejection fraction; VINDICATE = VitamIN D treatIng patients with Chronic heArT failurE.
Central Illustration
Central Illustration
Vitamin D in Chronic Heart Failure: Impact on Left Ventricular Structure and Function Vitamin D improves left ventricular ejection fractions and reduces left ventricular dimensions and volumes.
See this image and copyright information in PMC

Comment in

References

    1. Heidenreich P.A., Albert N.M., Allen L.A., et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6:606–619. - PMC - PubMed
    1. Mosterd A., Hoes A.W. Clinical epidemiology of heart failure. Heart. 2007;93:1137–1146. - PMC - PubMed
    1. Cubbon R.M., Gale C.P., Kearney L.C., et al. Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction: a study across therapeutic eras. Circ Heart Fail. 2011;4:396–403. - PubMed
    1. Barker W.H., Mullooly J.P., Getchell W. Changing incidence and survival for heart failure in a well-defined older population, 1970–1974 and 1990–1994. Circulation. 2006;113:799–805. - PubMed
    1. Jhund P.S., Macintyre K., Simpson C.R., et al. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation. 2009;119:515–523. - PubMed

Publication types

MeSH terms

Associated data